Dr Michel Pairet, Member of the Board of Managing Directors, Innovation Unit, Boehringer Ingelheim, discloses about the company’s strategic plans for both, global and the Indian markets, in an exclusive interaction with Sanjiv Das.
At the annual press conference in Ingelheim, several investments in China were announced. What is BI’s strategy when it comes to investing in India?
In 2017, Boehringer Ingelheim (BI) in India invested 125,000 euros in property, plant and equipment. BI India has a focused strategy of bringing its innovation-based research molecules to India to address evolving needs of the patients. Co-marketing partnerships have also played a major role in strengthening our presence and reaching a larger target audience.
The key focus for Boehringer Ingelheim India is diabetes, stroke, oncology and respiratory. Our launches over the last few years are Pradaxa (dabigatran for stroke prevention in atrial fibrillation) and Trajenta (linagliptin in diabetes) in 2012, Trajenta Duo (FDC of linagliptin and metformin) in 2014, followed by the launch of Xovoltib (afatinib) for NSCLC and co-marketing agreement with Lupin for the launch of 2nd brand of linagliptin and linagliptin-metformin under the brand names Ondero and Ondero Met respectively in 2015.
In 2016, we launched Jardiance (empagliflozin) in diabetes and had a strategic partnership with Lupin for the 2nd brand of empagliflozin, under the brand name Gibtulio. In 2017, Boehringer Ingelheim India entered the respiratory space with the launch of Cyendiv (nintedanib) for IPF (Idiopathic Pulmonary Fibrosis). This year saw the launch of FDCs Jardiance Met (empagliflozin-metformin) and Glyxambi (empagliflozin-linagliptin) as well as the expansion of our collaboration with Lupin for co-marketing of two oral antidiabetic drugs Gibtulio Met (empagliflozin – metformin) and Ajaduo (empagliflozinLinagliptin).
هذه القصة مأخوذة من طبعة August 16-31, 2018 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 16-31, 2018 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
MAKING SUSTAINABILITY SUSTAINABLE
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability
New energy recovery system for tablet coaters
Upto 50 per cent less steam energy consumption
The future of pharma logistics: Trends, challenges, and opportunities
Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.